Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Announcement of Executive Appointments and Organizational Changes
JCR Establishes Advanced Biopharmaceutical Research Institute
JCR Pharmaceuticals Supports Rare Disease Day 2026
JCR Organizes and Conducts API Plant Tour for Individual Shareholders
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
Recognition of Subsidy Income as Extraordinary Income
Revision of Consolidated Financial Forecasts for Fiscal Year Ended March 31, 2026
Consolidated Financial Results for the Nine Months ended December 31, 2025(FY2025) (Japanese standard)
FY2025 Third Quarter Results Briefing Session Material
JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium 2026
Briefing Session Material on the Agreement with Italfarmaco
JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare Disease
Notice of Personnel Change
JCR Organizes and Conducts API Plant Tour for Local Residents
Consolidated Financial Results for the Six Months ended September 30, 2025 (FY2025) (Japanese standard)
FY2025 Second Quarter Results Briefing Session Material
Shin Ashida of JCR Pharmaceuticals Named Kansai Regional Representative in EY Entrepreneur of The Year(TM) 2025 Japan
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology
JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] Across Nine MENAT Markets